Background: Although improved epicardial blood flow (as assessed with either TIMI flow grades or TIMI frame count) has been related to reduced mortality after administration of thrombolytic drugs, the relationship of myocardial perfusion (as assessed on the coronary arteriogram) to mortality has not been examined.

Methods And Results: A new, simple angiographic method, the TIMI myocardial perfusion (TMP) grade, was used to assess the filling and clearance of contrast in the myocardium in 762 patients in the TIMI (Thrombolysis In Myocardial Infarction) 10B trial, and its relationship to mortality was examined. TMP grade 0 was defined as no apparent tissue-level perfusion (no ground-glass appearance of blush or opacification of the myocardium) in the distribution of the culprit artery; TMP grade 1 indicates presence of myocardial blush but no clearance from the microvasculature (blush or a stain was present on the next injection); TMP grade 2 blush clears slowly (blush is strongly persistent and diminishes minimally or not at all during 3 cardiac cycles of the washout phase); and TMP grade 3 indicates that blush begins to clear during washout (blush is minimally persistent after 3 cardiac cycles of washout). There was a mortality gradient across the TMP grades, with mortality lowest in those patients with TMP grade 3 (2.0%), intermediate in TMP grade 2 (4.4%), and highest in TMP grades 0 and 1 (6.0%; 3-way P=0.05). Even among patients with TIMI grade 3 flow in the epicardial artery, the TMP grades allowed further risk stratification of 30-day mortality: 0.73% for TMP grade 3; 2.9% for TMP grade 2; 5.0% for TMP grade 0 or 1 (P=0.03 for TMP grade 3 versus grades 0, 1, and 2; 3-way P=0.066). TMP grade 3 flow was a multivariate correlate of 30-day mortality (OR 0.35, 95% CI 0.12 to 1.02, P=0.054) in a multivariate model that adjusted for the presence of TIMI 3 flow (P=NS), the corrected TIMI frame count (OR 1.02, P=0.06), the presence of an anterior myocardial infarction (OR 2.3, P=0.03), pulse rate on admission (P=NS), female sex (P=NS), and age (OR 1.1, P<0.001).

Conclusions: Impaired perfusion of the myocardium on coronary arteriography by use of the TMP grade is related to a higher risk of mortality after administration of thrombolytic drugs that is independent of flow in the epicardial artery. Patients with both normal epicardial flow (TIMI grade 3 flow) and normal tissue level perfusion (TMP grade 3) have an extremely low risk of mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.cir.101.2.125DOI Listing

Publication Analysis

Top Keywords

tmp grade
48
tmp
15
grade
14
myocardial perfusion
12
tmp grades
12
timi myocardial
8
mortality
8
mortality administration
8
administration thrombolytic
8
thrombolytic drugs
8

Similar Publications

Objective We evaluated the outcomes of tympanic membrane regenerative treatment using gelatin sponge, recombinant basic fibroblast growth factor (bFGF), and fibrin glue at Yokosuka Kyosai Hospital. Methodology We enrolled a total of 42 patients with tympanic membrane perforations (TMPs) (44 ears; right:left = 21:23) that were treated using gelatin sponge, recombinant bFGF, and fibrin glue between July 2020 and December 2023 at Yokosuka Kyosai Hospital. TMP closure rates, improvement of hearing level, and complications were retrospectively included in the evaluation items.

View Article and Find Full Text PDF

The risk of cytokine release syndrome (CRS) in patients with infections prior to chimeric antigen receptor T-cell (CAR T-cell) therapy represents an important and underreported event. Patients with active infections needing prompt CAR T-cell therapy to treat aggressive hematologic malignancies remain a clinical challenge. This case describes the clinical course of a 35-year-old male patient with relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma who received axicabtagene ciloleucel.

View Article and Find Full Text PDF
Article Synopsis
  • Primary percutaneous coronary intervention (PCI) can cause microvascular embolism by dislodging atherosclerotic debris, but thrombus aspiration (TA) before stenting in STEMI patients has shown benefits like reduced mortality and improved cardiac function.
  • A study involving 92 STEMI patients at Nguyen Tri Phuong Hospital revealed that those who underwent TA had better TIMI and TMP flow grades and higher ST-segment normalization rates, although major adverse cardiac events (MACEs) at 30 days and 12 months were similar between TA and non-TA groups.
  • The findings suggest that while TA can improve myocardial perfusion metrics in STEMI patients, it does not increase the risk of adverse outcomes, highlighting its potential role in enhancing coronary care
View Article and Find Full Text PDF

Objective: Systemic lupus erythematosus (SLE) patients receiving immunosuppressive therapy are at risk for opportunistic infections (OIs), particularly Pneumocystis pneumonia (PCP). This study aimed to evaluate the effectiveness of trimethoprim/sulfamethoxazole (TMP/SMX) as primary prophylaxis against OIs and its adverse effects in SLE patients receiving low-level immunosuppressive treatment in a real-world setting.

Methods: This open-label randomized controlled trial enrolled SLE patients receiving low-level immunosuppressive treatment at Ramathibodi Hospital between May 2021 and December 2022.

View Article and Find Full Text PDF
Article Synopsis
  • Idiopathic CD4 lymphocytopenia (ICL) is an immunodeficiency syndrome with persistent low CD4 counts and increased risk of opportunistic infections, notably including nocardiosis, which is rarely reported in ICL patients.
  • A 46-year-old woman with a history of pulmonary nocardiosis and ICL presented with symptoms after four years, where tests confirmed the presence of Nocardia otitidiscaviarum.
  • The case highlights the need for regular follow-up and CD4 count monitoring in ICL patients to prevent infections and emphasizes the relevance of secondary prophylaxis therapy following initial treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!